Avilex Pharma - Crunchbase Company Profile & Funding

Q: Who invested in Avilex Pharma?

Avilex Pharma is funded by Novo Holdings.

Q: When was the last funding round for Avilex Pharma?

Avilex Pharma closed its last funding round on obfuscated from a Venture - Series Unknown round.

Overview

Avilex Pharma

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Avilex Pharma

CB Rank

772344

A new treatment for ischemic stroke

Founded

obfuscation

Private

Venture - Series Unknown

Copenhagen, Hovedstaden, Denmark

1-10

www.avilexpharma.com

Biotechnology

Health Care

Medical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Key People

Kristian Strømgaard: Co-founder and CEO

Details

Operating Status

Active

Company Type

For Profit

About the Company

Avilex Pharma is a spin out from the University of Copenhagen, founded by Professor Kristian Strømgaard and Assis. Prof. Anders Bach of the Department of Drug Design and Pharmacology, with investment from Novo Seeds (part of Novo A/S) and Wellcome Trust.

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

AVLX-144

A PSD-95 inhibitor neuroprotectant drug candidate for treating acute ischemic stroke and subarachnoid hemorrhage.

Second Generation PSD-95 Inhibitors

New potent PSD-95 inhibitor compounds under preclinical development for neuroprotection in acute neurological conditions.

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Avilex Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Avilex Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Avilex Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Avilex Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Avilex Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Avilex Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Avilex Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Avilex Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Avilex Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Avilex Pharma	1	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Novo Holdings	—	Venture Round - Avilex Pharma	—
Novo Holdings	—	Venture Round - Avilex Pharma	—
Novo Holdings	—	Venture Round - Avilex Pharma	—
Novo Holdings	—	Venture Round - Avilex Pharma	—
Novo Holdings	—	Venture Round - Avilex Pharma	—